Topic: AS08-Treatment/AS08f-Clinical trials – Phase II-III: SELECT-MDS-1 TRIAL IN PROGRESS: A PHASE 3 RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL OF TAMIBAROTENE/AZACITIDINE VS PLACEBO/AZACITIDINE IN NEWLY DIAGNOSED (ND) ADULT PATIENTS SELECTED FOR RARA-POSITIVE HR-MDS. (May 2023)

Record Type:
Journal Article
Title:
Topic: AS08-Treatment/AS08f-Clinical trials – Phase II-III: SELECT-MDS-1 TRIAL IN PROGRESS: A PHASE 3 RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL OF TAMIBAROTENE/AZACITIDINE VS PLACEBO/AZACITIDINE IN NEWLY DIAGNOSED (ND) ADULT PATIENTS SELECTED FOR RARA-POSITIVE HR-MDS. (May 2023)
Main Title:
Topic: AS08-Treatment/AS08f-Clinical trials – Phase II-III: SELECT-MDS-1 TRIAL IN PROGRESS: A PHASE 3 RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL OF TAMIBAROTENE/AZACITIDINE VS PLACEBO/AZACITIDINE IN NEWLY DIAGNOSED (ND) ADULT PATIENTS SELECTED FOR RARA-POSITIVE HR-MDS
Authors:
Dezern, A.
Fenaux, P.
Deeren, D.
Campelo, M.
Lübbert, M.
Krishnamurthy, P.
Nagy, Z.
Basak, G.
Jonasova, A.
Geissler, K.
Ofran, Y.
Klimek, V.
Volkert, A.
Chisholm, J.
Hu, B.
Hodgson, G.
Roth, D.A.
Kelly, M.
Marconi, G.
Abstract:
Is Part Of:
Leukemia research. Volume 128(2023)Supplement
Journal:
Leukemia research
Issue:
Volume 128(2023)Supplement
Issue Display:
Volume 128, Issue 2023 (2023)
Year:
2023
Volume:
128
Issue:
2023
Issue Sort Value:
2023-0128-2023-0000
Page Start:
Page End:
Publication Date:
2023-05
Subjects:
Leukemia -- Periodicals
Leukemia -- Periodicals
Leucémie -- Périodiques
Leukemia
Periodicals
Electronic journals
Electronic journals
616.9941905
Journal URLs:
http://www.sciencedirect.com/science/journal/01452126 ↗
http://www.elsevier.com/journals ↗
DOI:
10.1016/j.leukres.2023.107269 ↗
Languages:
English
ISSNs:
0145-2126
Deposit Type:
Legaldeposit
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗
Physical Locations:
British Library DSC - 5185.270000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store
Ingest File:
27118.xml